---
title: "Definium Therapeutics, Inc. (DFTX.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/DFTX.US.md"
symbol: "DFTX.US"
name: "Definium Therapeutics, Inc."
industry: "Pharmaceuticals"
datetime: "2026-05-21T15:00:41.260Z"
locales:
  - [en](https://longbridge.com/en/quote/DFTX.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/DFTX.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/DFTX.US.md)
---

# Definium Therapeutics, Inc. (DFTX.US)

## Company Overview

Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company’s lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for the treatment of autism spectrum disorder. The company was formerly known as Mind Medicine (MindMed) Inc. and changed its name to Definium Therapeutics, Inc.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | US Market |
| Website | [definiumtx.com](https://definiumtx.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -9.58 | 184 | - | - | - |
| PB | 8.16 | 173 | 12.75 | 6.92 | 5.54 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-20T04:00:00.000Z

Total Analysts: **16**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 12 | 75% |
| Overweight | 4 | 25% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 21.50 |
| Highest Target | 70.00 |
| Lowest Target | 25.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/DFTX.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/DFTX.US/norm.md)
- [Related News](https://longbridge.com/en/quote/DFTX.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/DFTX.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**